Clinical Trials

1,978 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT03011684 2026-06-04

TALES

309 enrolled

Breast Neoplasms, Infertility

NCT07174336 2026-06-04

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

920 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01272037 2026-06-03

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

5,018 enrolled 14 charts

Carcinoma, Intraductal, Noninfiltrating

NCT05827081 2026-06-03

Adjuvant WIDER

1,400 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT06790693 2026-06-03

INAVO123

450 enrolled

Breast Neoplasms

NCT07492641 2026-06-03

KANDELA-302

1,056 enrolled

HR+/HER2- Breast Cancer

NCT06405178 2026-06-02

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Phase 3 Completed

200 enrolled

Polycystic Ovary Syndrome

NCT06671912 2026-06-02

LoTam

Phase 3 Suspended

1,156 enrolled

Breast Carcinoma In Situ

NCT07616973 2026-06-01

LET-CC-TAM

240 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT00310180 2026-05-29

TAILORx

10,273 enrolled 14 charts

Breast Neoplasms

NCT05952557 2026-05-28

CAMBRIA-2

5,500 enrolled

Breast Neoplasms

NCT06492616 2026-05-27

ELEGANT

4,220 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT07349069 2026-05-22

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

5,500 enrolled

Breast Neoplasms

NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

1,050 enrolled

Breast Neoplasm Female

NCT04546009 2026-05-19

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

992 enrolled

Breast Neoplasms

NCT06760637 2026-05-19

FourLight-3

1,035 enrolled

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

NCT06757634 2026-05-18

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

1,180 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT05512364 2026-05-15

TREAT ctDNA

220 enrolled

Breast Neoplasms

NCT06380751 2026-05-15

EvoPAR-BR01

500 enrolled

Advanced Breast Cancer

NCT07085767 2026-05-15

OPERA-02

1,000 enrolled

Breast Neoplasms

NCT02297438 2026-05-14

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Phase 3 Completed

340 enrolled 33 charts